Fatty Acid

© iStock

Science boss: Omega-3s could get boost by aping pharma doses

By RJ Whitehead

It was has a huge challenge for Nils Hoem, Aker Biomarine’s chief scientists, to understand the specifics of nutraceuticals when he first arrived at the Norwegian krill oil manufacturer in 2008 after a career in pharmaceuticals.

Newsweek wrote “Omega-3 Supplements Are a Waste of Money.” Well, maybe low-dose versions are...

Omega-3s and cognition: dosage matters!

By Adam Ismail

Yet another study questioning omega-3 efficacy has been picked up by the mainstream press. Why finger the nutrient when the dosage is all wrong? argues Adam Ismail, executive director of the Global Organisation for EPA and DHA Omega-3s (GOED), in this...

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers